Niki BioSolutions, Inc. 是一間臨床階段生物製藥公司,從事腫瘤及傳染病治療產品的發現、開發和商業化。
財務指標
營業收入
2025-12-31
$0
2025-09-30
$0
2024-12-31
$0
2024-09-30
--
營業支出
2025-12-31
$825.13K
2025-09-30
$589.63K
2024-12-31
-$558.59K
2024-09-30
$2.46M
淨利潤
2025-12-31
-$307.49K
2025-09-30
-$613.99K
2024-12-31
-$919.9K
2024-09-30
-$2.64M
淨利潤率
2025-12-31
--
2025-09-30
--
2024-12-31
--
2024-09-30
--
每股收益
2025-12-31
$-0.37
2025-09-30
$-0.85
2024-12-31
--
2024-09-30
--
息稅折舊攤銷前利潤
2025-12-31
-$825.13K
2025-09-30
-$589.63K
2024-12-31
$275.92K
2024-09-30
-$2.33M
有效稅率
2025-12-31
--
2025-09-30
--
2024-12-31
--
2024-09-30
--
項目
2025-12-31
2025-09-30
2024-12-31
2024-09-30
營業收入
$0
$0
$0
--
營業支出
$825.13K
$589.63K
-$558.59K
$2.46M
淨利潤
-$307.49K
-$613.99K
-$919.9K
-$2.64M
淨利潤率
--
--
--
--
每股收益
$-0.37
$-0.85
--
--
息稅折舊攤銷前利潤
-$825.13K
-$589.63K
$275.92K
-$2.33M
有效稅率
--
--
--
--
常見問題
NIKI stock refers to the publicly traded equity of the company represented by the ticker symbol NIKI. This security can be bought and sold on a stock exchange, allowing investors to own a fractional stake in the underlying business. For accurate details about the company, including its legal name and business operations, refer to the stock profile information available on this page.
NIKI's share price can be influenced by company-specific developments, such as financial results, management changes, or strategic announcements. Broader market trends, industry conditions, and economic factors like interest rates and inflation may also affect investor sentiment. Additionally, changes in regulations or competitive dynamics within NIKI's sector can impact how the stock trades. Monitoring official filings and reliable news sources can help investors understand these influences.
The current price of NIKI stock fluctuates throughout the trading day based on supply and demand. To view the latest price, check the real-time quote displayed at the top of this page. That figure reflects the most recent trade and is updated regularly during market hours, providing an accurate snapshot of where NIKI is trading at any given moment.
Evaluating NIKI's valuation involves reviewing metrics such as the price-to-earnings ratio, price-to-sales ratio, and price-to-book ratio, and comparing them with industry peers and historical averages. Analysts also consider growth prospects and profitability. Since valuation is not a precise science, it is helpful to use multiple metrics and understand the company's business model before drawing conclusions about whether NIKI appears overvalued or undervalued.
To buy NIKI stock, you need a brokerage account with a registered broker that offers access to the exchange where NIKI is listed. Once your account is funded, you can place a market or limit order for NIKI shares during regular trading hours. The exact process varies by broker, but most platforms provide a simple search function to locate NIKI by its ticker symbol and execute a trade.
Like any stock, NIKI carries market risk, meaning its price can decline due to broad economic or market downturns. Company-specific risks may include operational challenges, competitive pressures, or financial underperformance. Additionally, liquidity risk could affect how easily shares are traded without impacting the price. Reviewing NIKI's risk factors in its regulatory filings and staying informed about its industry can help investors assess these risks.